Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619 1626
This examiner grants 40% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19355572 | PARABEN-FREE FEXOFENADINE FORMULATIONS | Final Rejection | Opella Healthcare Group SAS |
| 18348787 | DENSIFIED CO-PRECIPITATED MATERIALS ISOLATED BY THIN FILM EVAPORATION | Non-Final OA | Merck Sharp & Dohme LLC |
| 18261523 | PHARMACEUTICAL COMPOSITION | Non-Final OA | Novartis AG |
| 19307513 | Sublingual Formulation of Anticancer Compound for Use in the Treatment of Autoimmune Neurodegenerative Diseases | Non-Final OA | Vektor Pharma TF GmbH |
| 16204591 | THICK CLEANSING COMPOSITIONS | Final Rejection | L'OREAL |
| 17642829 | FLYING PEST CONTROL COMPOSITION AND FLYING PEST CONTROL SPRAY | Final Rejection | Kao Corporation |
| 16976023 | Tetraselmis Extract | Final Rejection | SYMRISE AG |
| 17309195 | Deodorant Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18176294 | TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR | Non-Final OA | Incyte Corporation |
| 18706245 | HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONS | Non-Final OA | Conopco, Inc., d/b/a Unilever |
| 18516195 | PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS | Non-Final OA | YALE UNIVERSITY |
| 17768166 | TARGETED BIFUNCTIONAL DEGRADERS | Non-Final OA | YALE UNIVERSITY |
| 18499252 | HIGH TEMPERATURE RESISTANT PROBIOTICS FOR FOOD OR BEVERAGE AND METHOD OF MAKING THE SAME | Non-Final OA | Nano and Advanced Materials Institute Limited |
| 18757769 | Anti-Obesity Agent, Anti-Dementia Agent, Deodorant, Anti-Aging Agent, Anti-Glycation Agent, Anti-Type I Allergy Agent, Hypotensive Agent, Flavor Improving Agent, Muscle Enhancing Agent, and Bone Metabolism Improving Agent | Non-Final OA | Mitsui DM Sugar Co., Ltd. |
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | Final Rejection | KEMIN INDUSTRIES, INC. |
| 18692081 | POWDER COSMETIC | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 17261354 | COLOR MIXING SYSTEM FOR COSMETIC COMPOSITION | Final Rejection | Amorepacific Corporation |
| 17995542 | MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE | Final Rejection | Research Triangle Institute |
| 18681221 | SCALP MICROBIOME COMPLEX AND USE THEREOF FOR IMPROVING HAIR OR SCALP CONDITION | Non-Final OA | COSMAX, INC. |
| 17597703 | MULTILAYER SHEET | Non-Final OA | Eastman Chemical Company |
| 17611338 | METHODS FOR ENCAPSULATION | Non-Final OA | Chr. Hansen A/S |
| 18291685 | PHARMACEUTICAL COMPOSITION COMPRISING POLYSACCHARIDE | Non-Final OA | EVER SUPREME BIO TECHNOLOGY CO. LTD |
| 17620147 | ANTIMICROBIAL PEPTIDE-SELENIUM NANOPARTICLES | Non-Final OA | The University of Melbourne |
| 17978236 | SPHEROIDS FOR SUPPRESSING IMMUNE REJECTION AND USES THEREOF | Non-Final OA | RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY |
| 18563331 | COATING FOR MEDICAL DEVICES | Non-Final OA | SMART REACTORS SERVICE LIMITED |
| 17962770 | RELOADABLE MICROCAPSULES | Final Rejection | INTERNATIONAL FLAVORS & FRAGRANCES INC. |
| 17802054 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | Final Rejection | HK INNO.N CORPORATION |
| 17604994 | FILM, CAPSULE AND FILM-FORMING COMPOSITION COMPRISING WATER-SOLUBLE SALT AS OPACIFYING AGENT | Non-Final OA | Capsugel Belgium NV |
| 17863099 | NANOBUBBLE-CONTAINING COSMETIC | Final Rejection | H4 Co., Ltd. |
| 18268118 | USE OF SYNTHETIC PEPTIDE FOR THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNITY | Non-Final OA | CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy